Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies Cancer Immunol Immunother, 67 (2018), pp. 1833-1844 CrossrefView in ScopusGoogle Scholar 6 M.A. Postow, R. Sidlow, M.D. Hellmann Immune-...
A. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches. J. Thorac Oncol. 8, 587–598 (2013). CAS PubMed Google Scholar Rudin, C. M. et al. Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-...
it does not cause the phenomena. Rather, it has been shown that there is an increase in enzymatic activity as the cells enter a senescent state. This hydrolase enzyme resides in lysosomes and converts β-galactosides into monosaccharides under acidic...
Meanwhile, IDO1 is expressed by either tumor cells or tumor-associated immune cells in 99 % or 94 % patients with NPC using 1 % cutoff value of immunohistochemistry and negatively associated with OS[120]. Furthermore, an immune checkpoint-based signature classifier, in which IDO1 is ...
Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade. JAMA Oncol. 2018;5:471–8. Article PubMed Central Google Scholar Goeppert B, Roessler S, Renner M, et al. Mismatch repair deficiency is a rare but putative therapeutically ...
Survival of patients with advanced metastatic melanoma: the impact of MAP kinase pathway inhibition and immune checkpoint inhibition—update 2019. Eur J Cancer. 2020;130:126–38. Article CAS PubMed Google Scholar Kreidieh FY, Tawbi HA. The introduction of LAG-3 checkpoint blockade in melanoma:...
Immune checkpoint blockade (ICB) therapy has recently emerged as a significant clinical breakthrough in the treatment of advanced malignancies117,118. Although a series of ICIs, such as PD-1 and CTLA-4 inhibitors, have proven successful in a range of malignancies, there are subsets of patients ...
checkpoints… Children under 18 are not required to provide identification when traveling within the United States… REAL ID-compliant cards have a star marking on the upper top portion of the card. If the card does not have one of these markings, it is not REAL ID-compliant and won’t ...
This suggests that meflin is a functional marker of rCAFs in PDAC [192, 194]. Meflin+ CAFs are associated with a favorable therapeu- tic response to immune checkpoint blockade in patients with NSCLC. In NSCLC patients and mouse syngeneic tumor models, large numbers of m eflin+ CAFs ...
Preclinical mouse models have also shown that KRAS G12C inhibitors with immune checkpoint blockade have a synergistic benefit [91]. The CodeBreaK 100/101 study, which enrolled 58 patients (67 % of patients had received a previous IO), evaluated the safety and efficacy of pembrolizumab or atezol...